Evidence mapPaperPMID 40646563Full record

ReviewJournal of neuroinflammation2025

Cholesterol in the CNS: functions, recycling and remyelination.

Emily C Wuerch, V Wee Yong

Abstract readReview
In one paragraph

Review in Journal of neuroinflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Resetting immunometabolic set points in autoimmune disease.Journal of translational autoimmunity · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Emily C WuerchHotchkiss Brain Institute, Department of Clinical Neurosciences, University of Calgary Calgary, 3330 Hospital Drive NW, Calgary, Alberta, T2N 4N1, Canada.
V Wee YongHotchkiss Brain Institute, Department of Clinical Neurosciences, University of Calgary Calgary, 3330 Hospital Drive NW, Calgary, Alberta, T2N 4N1, Canada. vyong@ucalgary.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cholesterol plays critical roles throughout the body, including its function in cellular membrane formation and as a precursor for hormones and bile acids. Notably, the brain contains 25% of the body’s cholesterol, which remains separate from peripheral sources. Consequently, cholesterol within the central nervous system (CNS) must be efficiently recycled among neural cells, and disruptions in this recycling and metabolism have pathological consequences. This review explores the physiological functions of cholesterol particularly in the CNS, highlights lipid metabolism and recycling mechanisms within CNS cells for remyelination, and examines the role of cholesterol dysregulation in multiple sclerosis. Finally, we discuss therapeutic approaches targeting cholesterol metabolism, including statins, cyclodextrins and liver X receptor (LXR) agonists.

Indexed as

Central Nervous SystemCholesterolRemyelinationAnimalsHumansLipid MetabolismCholesterolCholesterolLipid recyclingNeurological diseaseRemyelinationTherapeutics

Identifiers

PMID40646563
PMCPMC12255092

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.